A Phase 2, Open-label Study to Evaluate the Efficacy and Safety of KB195 in Subjects with a Urea Cycle Disorder with Inadequate Control on Standard of Care

drug protocol number
K020-218
drug sponsor
Kaleido Biosciences
drug study
KB195
drug trial site
KKUH
drug status
Completed
drug phase